About the Product

Description


Desmopressin 60mcg tablet is a synthetic vasopressin analog used for managing diabetes insipidus, nocturnal polyuria, and related urinary disorders.

It works by reducing urine production through its antidiuretic effect, helping patients maintain fluid balance and minimize excessive urination, especially during nighttime.

This tablet is widely prescribed in central diabetes insipidus, adult nocturia, and urinary frequency disorders, providing improved patient comfort and daily convenience.

With strong clinical relevance in endocrinology and urology therapy, growing physician trust, and increasing demand in urinary management, this formulation strengthens clinical and outpatient therapy portfolios and supports sustained therapeutic utilization.

Some patients may experience headache, mild nausea, abdominal discomfort, or water retention. Rarely, hyponatremia (low sodium), swelling, confusion, or allergic reactions may occur. Any severe or unusual symptoms should be reported to a healthcare professional immediately.

Desmoprin 60 Tablet is indicated for the treatment of: Nocturnal enuresis (bedwetting) in children and adults Central diabetes insipidus Conditions related to excessive urination due to deficient antidiuretic hormone

This medicine should be used under medical supervision. Patients with kidney, heart, or electrolyte imbalance issues should consult their doctor before use. Strict adherence to the prescribed dosage is essential to prevent water retention or electrolyte disturbances.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Desmopressin 60mcg Tablet in the PCD pharma franchise market?

Desmopressin 60mcg Tablet has strong demand in the endocrinology and specialty care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include Desmopressin Tablets in their product range?

Medical distributors and wholesalers can benefit from consistent demand in the management of diabetes insipidus, nocturnal enuresis, and related hormonal disorders under specialist supervision. It strengthens their endocrinology and specialty medicine portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Desmopressin 60mcg Tablet?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Desmopressin 60mcg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this specialty medicine?

Wholesalers and medical agencies benefit from steady prescription demand, repeat therapy usage, and specialty doctor support when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Desmopressin 60mcg Tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this endocrinology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.